Abstract
Consumption of dietary supplements by millions of people is increasing [1]. Between 64 to 81% of cancer patients and survivors use multivitamin supplements after the cancer diagnosis [2]. The use of antioxidants during cancer therapy has been a hot topic in medical science for the last 20 years without clear answers and recommendations. It seems that antioxidants are able to I) decrease the cancer formation risk by quenching ROS that are involved in cancer initiation and progression and II) assist in survival of cancer/precancer cells once the malignant transformation already occurred. Antioxidants were shown to assist cancer initiation, interfere with cancer treatment by reducing its efficacy and patient survival, and vice versa, there are reports of beneficial antioxidant effect during the cancer treatment.
Keywords: Antioxidants, cancer, beta carotene, vitamin E, selenium, vitamin C.
[1]
Centers for Disease Control and Prevention. National Center for Health Statistics. Dietary Supplement Use Among U.S. Adults has Increased Since NHANES III (1988-1994). NCHS Data Brief No 61 2011. April ; [Retrieved on June 27, 2018];
[2]
Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: A systematic review. J Clin Oncol 2008; 26(4): 665-73.
[3]
Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: A review. J Am Diet Assoc 1996; 96(10): 1027-39.
[7]
Willett WC. Fruits, vegetables, and cancer prevention: turmoil in the produce section. J Natl Cancer Inst 2010; 102(8): 510-1.
[8]
George SM, Park Y, Leitzmann MF, et al. Fruit and vegetable intake and risk of cancer: A prospective cohort study. Am J Clin Nutr 2009; 89(1): 347-53.
[9]
Tanaka T, Sugie S. Inhibition of colon carcinogenesis by dietary non-nutritive compounds. J Toxicol Pathol 2007; 20: 215-35.
[10]
Poljšak B, Fink R. The protective role of antioxidants in the defence against ROS/RNS-mediated environmental pollution. Oxid Med Cell Longev 2014; 2014: 671539.
[11]
Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998; 56(11): 317-33.
[12]
Cherubini A, Vigna GB, Zuliani G, Ruggiero C, Senin U, Fellin R. Role of antioxidants in atherosclerosis: epidemiological and clinical update. Curr Pharm Des 2005; 11(16): 2017-32.
[13]
Lotito SB, Frei B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic Biol Med 2006; 41(12): 1727-46.
[14]
Milligan SA, Burke P, Coleman DT, et al. The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells. Clin Cancer Res 2009; 15(15): 4885-94.
[15]
Lee JS, Surh YJ. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett 2005; 224(2): 171-84.
[16]
Abbas A, Patterson W III, Georgel PT. The epigenetic potentials of dietary polyphenols in prostate cancer management. Biochem Cell Biol 2013; 91(6): 361-8.
[17]
Bautista DM, Movahed P, Hinman A, et al. Pungent products from garlic activate the sensory ion channel TRPA1. Proc Natl Acad Sci USA 2005; 102(34): 12248-52.
[18]
Frescas D, Valenti L, Accili D. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J Biol Chem 2005; 280(21): 20589-95.
[19]
Borek C, Ong A, Mason H, Donahue L, Biaglow JE. Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms. Proc Natl Acad Sci USA 1986; 83(5): 1490-4.
[20]
Kågerud A, Peterson HI. Tocopherol in irradiation of experimental neoplasms. Influence of dose and administration. Acta Radiol Oncol 1981; 20(2): 97-100.
[21]
Gao P, Zhang H, Dinavahi R, et al. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell 2007; 12(3): 230-8.
[22]
Bonner MY, Arbiser JL. The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer. Future Med Chem 2014; 6(12): 1413-22.
[23]
Bonner MY, Arbiser JL. The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer. Future Med Chem 2014; 6(12): 1413-22.
[24]
Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993; 85(18): 1483-92.
[25]
Virtamo J, Pietinen P, Huttunen JK, et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: A postintervention follow-up. JAMA 2003; 290(4): 476-85.
[26]
Helzlsouer KJ, Huang HY, Alberg AJ, et al. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 2000; 92(24): 2018-23.
[27]
Weinstein SJ, Wright ME, Pietinen P, et al. Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study. J Natl Cancer Inst 2005; 97(5): 396-9.
[28]
Li H, Stampfer MJ, Giovannucci EL, et al. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 2004; 96(9): 696-703.
[29]
Zhuo H, Smith AH, Steinmaus C. Selenium and lung cancer: A quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiol Biomarkers Prev 2004; 13(5): 771-8.
[30]
Hurst R, Hooper L, Norat T, et al. Selenium and prostate cancer: systematic review and meta-analysis. Am J Clin Nutr 2012; 96(1): 111-22.
[31]
Sato R, Helzlsouer KJ, Alberg AJ, Hoffman SC, Norkus EP, Comstock GW. Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2002; 11(5): 451-7.
[32]
Heinonen OP, Huttunen JK, Albanes D, et al. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330(15): 1029-35.
[33]
Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334(18): 1150-5.
[34]
Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012; (3): CD007176.
[35]
Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011; 306(14): 1549-56.
[36]
Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women’s Health Study: A randomized controlled trial. JAMA 2005; 294(1): 56-65.
[37]
Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women’s Health Study. J Natl Cancer Inst 1999; 91(24): 2102-6.
[38]
Hercberg S, Galan P, Preziosi P, et al. The SU.VI.MAX Study: A randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004; 164(21): 2335-42.
[39]
Harvie M. Nutritional supplements and cancer: potential benefits and proven harms. Am Soc Clin Oncol Educ Book 2014; •••: e478-86.
[40]
Wang L, Sesso HD, Glynn RJ, et al. Vitamin E and C supplementation and risk of cancer in men: posttrial follow-up in the Physicians’ Health Study II randomized trial. Am J Clin Nutr 2014; 100(3): 915-23.
[41]
Zhang LR, Sawka AM, Adams L, Hatfield N, Hung RJ. Vitamin and mineral supplements and thyroid cancer: A systematic review. Eur J Cancer Prev 2013; 22(2): 158-68.
[42]
Pais R, Dumitraşcu DL. Do antioxidants prevent colorectal cancer? A meta-analysis. Rom J Intern Med 2013; 51(3-4): 152-63.
[43]
Drisko JA, Chapman J, Hunter VJ. The use of antioxidant therapies during chemotherapy. Gynecol Oncol 2003; 88(3): 434-9.
[45]
Khanzode SS, Muddeshwar MG, Khanzode SD, Dakhale GN. Antioxidant enzymes and lipid peroxidation in different stages of breast cancer. Free Radic Res 2004; 38(1): 81-5.
[46]
Sangeetha P, Das UN, Koratkar R, Suryaprabha P. Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic Biol Med 1990; 8(1): 15-9.
[47]
Weijl NI, Hopman GD, Wipkink-Bakker A, et al. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 1998; 9(12): 1331-7.
[48]
D’Andrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 2005; 55(5): 319-21.
[49]
Albanes D, Heinonen OP, Taylor PR, et al. α-Tocopherol and β-carotene supplements and lung cancer incidence in the α-tocopherol, β-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996; 88(21): 1560-70.
[50]
Conklin KA. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 2004; 3(4): 294-300.
[51]
Poljsak B, Milisav I. The neglected significance of “antioxidative stress”. Oxid Med Cell Longev 2012; 2012: 480895.
[52]
Schafer ZT, Grassian AR, Song L, et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 2009; 461(7260): 109-13.
[53]
Borek C, Pardo F. Vitamin E and apoptosis: A dual role. In: Pasquier
C, Ed Biennial Meeting of the Society for Free Radicals Research
International Paris, France 2002; pp July 16–20, 2002; Bologna,Italy . 2002-327-1.
[54]
Sigounas G, Anagnostou A, Steiner M. dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr Cancer 1997; 28(1): 30-5.
[55]
Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 2008; 100(11): 773-83.
[56]
Bairati I, Meyer F, Jobin E, et al. Antioxidant vitamins supplementation and mortality: A randomized trial in head and neck cancer patients. Int J Cancer 2006; 119(9): 2221-4.
[57]
Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med 2014; 6(222): 222ra18.
[58]
Bairati I, Meyer F, Gélinas M, et al. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol 2005; 23(24): 5805-13.
[59]
Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic efficacy: A systematic review of the evidence from randomized controlled trials. Cancer Treat Rev 2007; 33(5): 407-18.
[60]
Bairati I, Meyer F, Gélinas M, et al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst 2005; 97(7): 481-8.
[61]
Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med 2014; 6(221): 221ra15.
[62]
Le Gal K, Ibrahim MX, Wiel C, et al. Antioxidants can increase melanoma metastasis in mice. Sci Transl Med 2015; 7(308): 308re8.
[63]
Piskounova E, Agathocleous M, Murphy MM, et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 2015; 527(7577): 186-91.
[64]
The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330(15): 1029-35.
[65]
Lesperance ML, Olivotto IA, Forde N, et al. Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: An historical cohort study. Breast Cancer Res Treat 2002; 76(2): 137-43.
[66]
Seixas-Silva JA Jr, Richards T, Khuri FR, et al. Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-up. Arch Otolaryngol Head Neck Surg 2005; 131(4): 304-7.
[67]
Prasad KN, Kumar B, Yan XD, Hanson AJ, Cole WC. Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: A review. J Am Coll Nutr 2003; 22(2): 108-17.
[68]
Yu W, Jia L, Wang P, et al. In vitro and in vivo evaluation of anticancer actions of natural and synthetic vitamin E forms. Mol Nutr Food Res 2008; 52(4): 447-56.
[69]
Jaakkola K, Lähteenmäki P, Laakso J, Harju E, Tykkä H, Mahlberg K. Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with small-cell lung cancer. Anticancer Res 1992; 12(3): 599-606.
[70]
Simone CB II, Simone NL, Simone V, Simone CB. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2. Altern Ther Health Med 2007; 13(2): 40-7.
[71]
Borek C, Ong A, Mason H. Distinctive transforming genes in x-ray-transformed mammalian cells. Proc Natl Acad Sci USA 1987; 84(3): 794-8.
[72]
Kennedy M, Bruninga K, Mutlu EA, Losurdo J, Choudhary S, Keshavarzian A. Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C. Am J Gastroenterol 2001; 96(4): 1080-4.
[73]
Zirpoli GR, McCann SE, Sucheston-Campbell LE, et al. Supplement use and chemotherapy‐induced peripheral neuropathy in a cooperative group trial (S0221): The DELCaP Study. J Natl Cancer Inst 2017; 109(12): djx098.
[74]
Greenlee H, Hershman DL, Shi Z, et al. BMI, lifestyle factors and taxane-induced neuropathy in breast cancer patients: The Pathways Study. J Natl Cancer Inst 2016; 109(2): 1-8.
[75]
Ligibel JA. Editorial: Supplements and Chemotherapy-Induced Peripheral Neuropathy: Hope or Hype? J Natl Cancer Inst 2017; 109(12)
[76]
Pathak AK, Bhutani M, Guleria R, et al. Chemotherapy alone vs. chemotherapy plus high dose multiple antioxidants in patients with advanced non small cell lung cancer. J Am Coll Nutr 2005; 24(1): 16-21.
[77]
Moss RW. Do antioxidants interfere with radiation therapy for cancer? Integr Cancer Ther 2007; 6(3): 281-92.
[78]
Simone CB II, Simone NL, Simone V, Simone CB. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1. Altern Ther Health Med 2007; 13(1): 22-8.
[79]
Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic toxicity: A systematic review of the evidence from randomized controlled trials. Int J Cancer 2008; 123(6): 1227-39.
[80]
Lissoni P, Chilelli M, Villa S, Cerizza L, Tancini G. Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: A randomized trial. J Pineal Res 2003; 35(1): 12-5.
[81]
Lissoni P, Barni S, Mandalà M, et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer 1999; 35(12): 1688-92.
[82]
Gomez-Cabrera MC, Domenech E, Romagnoli M, et al. Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance. Am J Clin Nutr 2008; 87(1): 142-9.
[83]
Gliemann L, Schmidt JF, Olesen J, et al. Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. J Physiol 2013; 591(20): 5047-59.
[84]
Donato AJ, Uberoi A, Bailey DM, Wray DW, Richardson RS. Exercise-induced brachial artery vasodilation: effects of antioxidants and exercise training in elderly men. Am J Physiol Heart Circ Physiol 2010; 298(2): H671-8.
[85]
Strobel NA, Peake JM, Matsumoto A, Marsh SA, Coombes JS, Wadley GD. Antioxidant supplementation reduces skeletal muscle mitochondrial biogenesis. Med Sci Sports Exerc 2011; 43(6): 1017-24.
[86]
Ristow M, Zarse K, Oberbach A, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA 2009; 106(21): 8665-70.
[87]
Richardson RS, Donato AJ, Uberoi A, et al. Exercise-induced brachial artery vasodilation: role of free radicals. Am J Physiol Heart Circ Physiol 2007; 292(3): H1516-22.
[88]
Rhee SG. Redox signaling: hydrogen peroxide as intracellular messenger. Exp Mol Med 1999; 31(2): 53-9.
[89]
Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta 2016; 1863(12): 2977-92.
[90]
Espinosa-Diez C, Miguel V, Mennerich D, et al. Antioxidant responses and cellular adjustments to oxidative stress. Redox Biol 2015; 6: 183-97.
[91]
Poljsak B. Strategies for reducing or preventing the generation of oxidative stress. Oxid Med Cell Longev 2011; 2011: 194586.
[92]
Rotblat B, Melino G, Knight RA. NRF2 and p53: Januses in cancer? Oncotarget 2012; 3(11): 1272-83.
[93]
Sporn MB, Liby KT. NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer 2012; 12(8): 564-71.
[94]
Salganik RI. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 2001; 20(5)(Suppl.): 464S-72S.
[95]
Poljsak B, Raspor P. The antioxidant and pro-oxidant activity of vitamin C and trolox in vitro: A comparative study. J Appl Toxicol 2008; 28(2): 183-8.
[96]
Poljšak B, Gazdag Z, Pesti M, et al. Pro-oxidative versus antioxidative reactions between Trolox and Cr(VI): The role of H(2)O(2). Environ Toxicol Pharmacol 2006; 22(1): 15-9.
[97]
Mursu J, Robien K, Harnack LJ, Park K, Jacobs DR Jr. Dietary supplements and mortality rate in older women: the Iowa Women’s Health Study. Arch Intern Med 2011; 171(18): 1625-33.
[98]
Halliwell B, Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984; 219(1): 1-14.
[99]
Pryor W. Free radicals and lipid peroxidation: What they are and how they got that way.Natural antioxidants in human health and disease 1994; 1-19.
[100]
Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br Med Bull 49:481-493. Chem Biol Interact 1993; 160(1): 1-40.
[101]
Lodish H, Berk A, Matsudaira P, Kaiser CA, Krieger M, Scott MP, et al. Molecular Biology of the Cell. 5th ed. 2004.
[102]
Lutzky J, Astor MB, Taub RN, et al. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells. Cancer Res 1989; 49(15): 4120-5.
[103]
Cossarizza A, Franceschi C, Monti D, et al. Protective effect of N-acetylcysteine in tumor necrosis factor-alpha-induced apoptosis in U937 cells: the role of mitochondria. Exp Cell Res 1995; 220(1): 232-40.
[104]
Heaney ML, Gardner JR, Karasavvas N, et al. Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs. Cancer Res 2008; 68(19): 8031-8.
[105]
Fukumura H, Sato M, Kezuka K, et al. Effect of ascorbic acid on reactive oxygen species production in chemotherapy and hyperthermia in prostate cancer cells. J Physiol Sci 2012; 62(3): 251-7.
[106]
Li N, Sun C, Zhou B, et al. Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer. PLoS One 2014; 9(7): e100314.
[107]
Davison CA, Durbin SM, Thau MR, et al. Antioxidant enzymes mediate survival of breast cancer cells deprived of extracellular matrix. Cancer Res 2013; 73(12): 3704-15.
[108]
Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med 2014; 6(221): 221ra15.
[109]
Kapinova A, Stefanicka P, Kubatka P, et al. Are plant-based functional foods better choice against cancer than single phytochemicals? A critical review of current breast cancer research. Biomed Pharmacother 2017; 96: 1465-77.
[110]
Wu AH, Yu MC, Tseng CC, Hankin J, Pike MC. Green tea and risk of breast cancer in Asian Americans. Int J Cancer 2003; 106(4): 574-9.
[111]
Zhang M, Binns CW, Lee AH. Tea consumption and ovarian cancer risk: A case-control study in China. Cancer Epidemiol Biomarkers Prev 2002; 11(8): 713-8.
[112]
Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008; 98(1): 9-14.
[113]
Weiss JF, Landauer MR. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology 2003; 189(1-2): 1-20.
[114]
Weiss JF, Landauer MR. Radioprotection by antioxidants. Ann N Y Acad Sci. 2000;899:44-60; Borek C1. Antioxidant health effects of aged garlic extract. J Nutr 2001; 131(3s): 1010S-5S.
[115]
Pinto JT, Rivlin RS. Antiproliferative effects of allium derivatives from garlic. J Nutr 2001; 131(3s): 1058S-60S.
[116]
Xiao D, Pinto JT, Soh JW, et al. Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation. Cancer Res 2003; 63(20): 6825-37.
[117]
Cao HX, Zhu KX, Fan JG, Qiao L. Garlic-derived allyl sulfides in cancer therapy. Anticancer Agents Med Chem 2014; 14(6): 793-9.
[118]
Mira L, Fernandez MT, Santos M, Rocha R, Florêncio MH, Jennings KR. Interactions of flavonoids with iron and copper ions: A mechanism for their antioxidant activity. Free Radic Res 2002; 36(11): 1199-208.
[119]
Cherrak SA, Mokhtari-Soulimane N, Berroukeche F, et al. In Vitro Antioxidant versus Metal Ion Chelating Properties of Flavonoids: A Structure-Activity Investigation. PLoS One 2016; 11(10): e0165575.
[121]
Devassy JG, Nwachukwu ID, Jones PJ. Curcumin and cancer: barriers to obtaining a health claim. Nutr Rev 2015; 73(3): 155-65.
[122]
Karunagaran D, Rashmi R, Kumar TR. Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets 2005; 5(2): 117-29.
[123]
Basnet P, Skalko-Basnet N. Curcumin: An anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 2011; 16(6): 4567-98.
[124]
Deguchi A. Curcumin targets in inflammation and cancer. Endocr Metab Immune Disord Drug Targets 2015; 15(2): 88-96.
[125]
Zang S, Liu T, Shi J, Qiao L. Curcumin: A promising agent targeting cancer stem cells. Anticancer Agents Med Chem 2014; 14(6): 787-92.
[126]
Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004; 24(5A): 2783-840.
[127]
Siddiqui IA, Sanna V, Ahmad N, Sechi M, Mukhtar H. Resveratrol nanoformulation for cancer prevention and therapy. Ann N Y Acad Sci 2015; 1348(1): 20-31.
[128]
Wang H, Zhang H, Tang L, et al. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Toxicology 2013; 303: 139-46.
[129]
Carter LG, D’Orazio JA, Pearson KJ. Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer 2014; 21(3): R209-25.
[130]
Singh CK, Ndiaye MA, Ahmad N. Resveratrol and cancer: Challenges for clinical translation. Biochim Biophys Acta 2015; 1852(6): 1178-85.
[132]
Yun J, Mullarky E, Lu C, et al. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science 2015; 350(6266): 1391-6.
[133]
Chen Q, Espey MG, Sun AY, et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci USA 2008; 105(32): 11105-9.
[134]
Fritz H, Flower G, Weeks L, et al. Intravenous Vitamin C and Cancer: A Systematic Review. Integr Cancer Ther 2014; 13(4): 280-300.
[135]
Jacobs C, Hutton B, Ng T, Shorr R, Clemons M. Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review. Oncologist 2015; 20(2): 210-23.
[136]
Wang H, Khor TO, Shu L, et al. Plants vs. cancer: A review on natural phytochemicals in preventing and treating cancers and their druggability. Anticancer Agents Med Chem 2012; 12(10): 1281-305.
[137]
Seto NO, Hayashi S, Tener GM. Overexpression of Cu-Zn superoxide dismutase in Drosophila does not affect life-span. Proc Natl Acad Sci USA 1990; 87(11): 4270-4.
[138]
Orr WC, Sohal RS. Effects of Cu-Zn superoxide dismutase overexpression of life span and resistance to oxidative stress in transgenic Drosophila melanogaster. Arch Biochem Biophys 1993; 301(1): 34-40.
[139]
Mockett RJ, Orr WC, Rahmandar JJ, et al. Overexpression of Mn-containing superoxide dismutase in transgenic Drosophila melanogaster. Arch Biochem Biophys 1999; 371(2): 260-9.
[140]
Fraga CG, Shigenaga MK, Park JW, Degan P, Ames BN. Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 1990; 87(12): 4533-7.
[141]
Oliver CN, Ahn BW, Moerman EJ, Goldstein S, Stadtman ER. Age-related changes in oxidized proteins. J Biol Chem 1987; 262(12): 5488-91.
[142]
Hamilton ML, Van Remmen H, Drake JA, et al. Does oxidative damage to DNA increase with age? Proc Natl Acad Sci USA 2001; 98(18): 10469-74.
[143]
Ralser M, Benjamin IJ. Reductive stress on life span extension in C. elegans. BMC Res Notes 2008; 1: 19.
[144]
Poljsak B, Milisav I. What Doesn’t Kill Us, Makes Us Stronger: Reducing Oxidative Stress and Damage Through Adaptive Stress Responses. Human Anatomy and Physiology 2014.
[145]
Poljsak B. Seyfried et al, Reduction of Sporadic Malignancies by Stimulation of Cellular Repair Systems and by Targeting Cellular Energy Metabolism. Cancer Etiology, Diagnosis and Treatments 2017.
[146]
Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: A systematic review and meta-analysis. Lancet 2004; 364(9441): 1219-28.
[147]
Bjelakovic G, Nikolova D, Gluud LL, et al. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases Cochrane review 2012; 14(3) CD007176.
[148]
Miller ER III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142(1): 37-46.
[149]
Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003; 361(9374): 2017-23.
[150]
Caraballoso M, Sacristan M, Serra C, Bonfill X. Drugs for preventing lung cancer in healthy people. Cochrane Database Syst Rev 2003; (2): CD002141.
[151]
Argüelles S, Gómez A, Machado A, Ayala A. A preliminary analysis of within-subject variation in human serum oxidative stress parameters as a function of time. Rejuvenation Res 2007; 10(4): 621-36.
[152]
WHO 2017.http://www.who.int/elena/ titles/fruit_vegetables_ ncds/en/ [Retrieved on June 30, 2018];
Related Journals
Current Drug Safety
Current Medicinal Chemistry
Current Neuropharmacology
Current Pharmaceutical Analysis
Current Topics in Medicinal Chemistry
Current Vascular Pharmacology
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
CNS & Neurological Disorders - Drug Targets
Related Books
New Findings from Natural Substances
Mitochondrial DNA and the Immuno-inflammatory Response: New Frontiers to Control Specific Microbial Diseases
Pharmaceutical Chemistry and Production: An Introductory Textbook
Evidence-Based Research in Ayurveda against COVID-19 in Compliance with Standardized Protocols and Practices
Frontiers in Clinical Drug Research – Anti Allergy Agents
Pharmaceuticals for Targeting Coronaviruses
Medical Applications of Beta-Glucan
Nanotechnology Driven Herbal Medicine for Burns: From Concept to Application
Postbiotics: Science, Technology and Applications
Frontiers in Inflammation
Article Metrics
80
14
4
3